Acta Neuropathol

1. MANCA M, Standke HG, Browne DF, Huntley ML, et al
   Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
   Acta Neuropathol. 2023 May 8. doi: 10.1007/s00401-023-02574.
   

   >> Share

   
   

   
   Alzheimers Dement

2. MILLER MR, Lee YF, Kastanenka KV
   Calcium sensor Yellow Cameleon 3.6 as a tool to support the calcium hypothesis of Alzheimer's disease.
   Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13111.
   

   >> Share

   
   
3. QUINNEY SK, Murugesh K, Oblak A, Onos KD, et al
   STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease.
   Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13108.
   

   >> Share

   
   
4. D'ALESSANDRO A, Lukens JR, Zimring JC
   The role of PIMT in Alzheimer's disease pathogenesis: A novel hypothesis.
   Alzheimers Dement. 2023 May 8. doi: 10.1002/alz.13115.
   

   >> Share

   
   
5. SHULMAN D, Dubnov S, Zorbaz T, Madrer N, et al
   Sex-specific declines in cholinergic-targeting tRNA fragments in the nucleus accumbens in Alzheimer's disease.
   Alzheimers Dement. 2023 May 9. doi: 10.1002/alz.13095.
   

   >> Share

   
   
6. CHUNG J, Sahelijo N, Maruyama T, Hu J, et al
   Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.
   Alzheimers Dement. 2023 May 11. doi: 10.1002/alz.13069.
   

   >> Share

   
   

   
   Am J Alzheimers Dis Other Demen

7. WEI Z, Li D, Shi J
   Alterations of Spatial Memory and Gut Microbiota Composition in Alzheimer's Disease Triple-Transgenic Mice at 3, 6, and 9 Months of Age.
   Am J Alzheimers Dis Other Demen. 2023;38:15333175231174193.
   

   >> Share

   
   

   
   BMC Geriatr

8. LIN Y, Yu N, Lin X, Deng X, et al
   Preoperative cerebrospinal fluid biomarkers may be associated with postoperative delirium in patients undergoing knee/hip arthroplasty: the PNDABLE study.
   BMC Geriatr. 2023;23:282.
   

   >> Share

   
   

   
   Brain

9. YOUNES K, Sha SJ
   The MVP or the tombstone: is tau the correct target to treat Alzheimer's disease?
   Brain. 2023 May 8:awad151. doi: 10.1093.
   

   >> Share

   
   

   
   J Alzheimers Dis

10. GRISANTI SG, Massa F, Chincarini A, Pretta S, et al
    Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2023;93:75-86.
    

    >> Share

    
    
11. WEIDUNG B, Lovheim H, Littbrand H, Wahlin J, et al
    Temporal Dementia and Cognitive Impairment Trends in the Very Old in the 21st Century.
    J Alzheimers Dis. 2023;93:61-74.
    

    >> Share

    
    
12. KREBS C, Brill E, Minkova L, Federspiel A, et al
    Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline.
    J Alzheimers Dis. 2023;93:107-124.
    

    >> Share

    
    
13. UMFLEET LG, Bilder RM, Loring DW, Thames A, et al
    The Future of Cognitive Screening in Neurodegenerative Diseases.
    J Alzheimers Dis. 2023;93:47-59.
    

    >> Share

    
    
14. LANOOIJ SD, Eisel ULM, van der Zee EA, Kas MJH, et al
    Variation in Group Composition Alters an Early-Stage Social Phenotype in hAPP-Transgenic J20 Mice.
    J Alzheimers Dis. 2023;93:211-224.
    

    >> Share

    
    
15. JANG S, Chorna N, Rodriguez-Graciani KM, Inyushin M, et al
    The Effects of Amyloid-beta on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells.
    J Alzheimers Dis. 2023;93:307-319.
    

    >> Share

    
    
16. LV X, Chu M, Liu Y, Jing D, et al
    Neurofunctional Correlates of Activities of Daily Living in Patients with Posterior Cortical Atrophy.
    J Alzheimers Dis. 2023;93:295-305.
    

    >> Share

    
    
17. RODRIGUES MARTINS D, Vandermeeren M, Van Kolen K, Brepoels E, et al
    Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid.
    J Alzheimers Dis. 2023;93:151-167.
    

    >> Share

    
    
18. TETLOW AM, Jackman BM, Alhadidy MM, Perumal V, et al
    Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy.
    J Alzheimers Dis. 2023;93:365-378.
    

    >> Share

    
    
19. GAO Y, Liu Y, Zhang Y, Wang Y, et al
    Olfactory Threshold Test as a Quick Screening Tool for Cognitive Impairment: Analysis of Two Independent Cohorts.
    J Alzheimers Dis. 2023;93:169-178.
    

    >> Share

    
    
20. PARKA A, Volbracht C, Hall B, Bastlund JF, et al
    Visual Evoked Potentials as an Early-Stage Biomarker in the rTg4510 Tauopathy Mouse Model.
    J Alzheimers Dis. 2023;93:247-262.
    

    >> Share

    
    
21. KAWAKATSU S, Kobayashi R
    Towards Improved Clinical Diagnosis of Argyrophilic Grain Disease Using Brain Imaging.
    J Alzheimers Dis. 2023;93:389-392.
    

    >> Share

    
    

    
    JAMA

22. MARCUS R
    New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology Conference.
    JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389.
    

    >> Share

    
    

    
    Neurobiol Aging

23. PAPADATOS Z, Phillips NA
    Olfactory function reflects episodic memory performance and atrophy in the medial temporal lobe in individuals at risk for Alzheimer's disease.
    Neurobiol Aging. 2023;128:33-42.
    

    >> Share

    
    

    
    Neurology

24. BUTLER PAGNOTTI RM, Pudumjee SB, Cross CL, Miller JB, et al
    Cognitive and Clinical Characteristics of Patients With Limbic-Predominant Age-Related TDP-43 Encephalopathy.
    Neurology. 2023;100:e2027-e2035.
    

    >> Share

    
    

    
    PLoS One

25. SHEPHERD-BANIGAN M, Miller KEM, Hastings SN, Schleiden LJ, et al
    Use of high cost care among Veterans with comorbid mental illness and Alzheimer's Disease and related dementias.
    PLoS One. 2023;18:e0282071.
    

    >> Share

    
    
26. MURPHY C, Dyer AH, Lawlor B, Kennelly SP, et al
    What is the impact of ongoing statin use on cognitive decline and dementia progression in older adults with mild-moderate Alzheimer disease?
    PLoS One. 2023;18:e0285529.
    

    >> Share

    
    
27. GATTO RG, Carlos AF, Reichard RR, Lowe VJ, et al
    Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer's & frontotemporal lobar degeneration patients.
    PLoS One. 2023;18:e0284182.
    

    >> Share

    
    
28. FARINA MP, Saenz J, Crimmins EM
    Does adding MRI and CSF-based biomarkers improve cognitive status classification based on cognitive performance questionnaires?
    PLoS One. 2023;18:e0285220.
    

    >> Share

    
    
29. TAULE T, Eide IS, Fjaer L, Myrberget MA, et al
    Norwegian version of the Edinburgh cognitive and behavioural ALS screen: Construct validity, internal consistency, inter-rater, and test-retest reliability.
    PLoS One. 2023;18:e0285307.
    

    >> Share

    
    

    
    Science

30. TRAVIS J
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science. 2023;380:571.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share